Women diagnosed with hematological malignancies during pregnancy face higher severe maternal morbidity and obstetric complications compared to post-pregnancy diagnoses. The study analyzed data from ...

In this free webinar, gain insight into new changes in molecular reclassification of hematologic malignancies and their effects in precision medicine. Attendees will learn about the use of molecular ...

This chart illustrates the trends in ASIR and ASMR of major hematological malignancies, including HL, NHL, MM, and leukemia, across the world, China, and the United States from 1990 to 2021. Based on ...

Findings showed Orca-T statistically significantly improved survival free of moderate to severe cGvHD vs alloHSCT at 1 year. The Food and Drug Administration (FDA) has accepted for Priority Review the ...

A research team has developed a new class of compounds that effectively inhibit both wild-type CDK9 and its drug-resistant mutant form, offering a promising strategy for treating hematological ...

Gallbladder cancer is often diagnosed late due to its asymptomatic nature in early stages, complicating treatment options. Diagnosis involves blood tests, imaging, and ERCP, with staging using the TNM ...

Lactic acidosis represents a challenging metabolic complication in patients with haematological malignancies. Notably, type B lactic acidosis occurs in the absence of hypoxia and is associated with ...

The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in ...

Global CAR T-cell Therapy Market OverviewThe global CAR T-cell therapy market is poised for exceptional growth, with an ...

The management of hematological malignancies (HM) in renally impaired patients may be a difficult task. Indeed, the kidney represents a major elimination pathway for many chemotherapeutic agents and ...